Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.82 USD | -0.80% | -20.48% | -42.72% |
May. 28 | Cytokinetics Closes $500 Million Stock Offering | MT |
May. 28 | JMP Securities Adjusts Cytokinetics Price Target to $78 From $106, Maintains Market Outperform Rating | MT |
Business Summary
Number of employees: 423
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Muscle Activators
100.0
%
| 95 | 100.0 % | 8 | 100.0 % | -92.04% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 95 | 100.0 % | 8 | 100.0 % | -92.04% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 60 | 98-06-30 |
Kari Loeser
CMP | Compliance Officer | - | 21-10-31 |
Stuart Kupfer
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Daniel Casper
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Fady Malik
CTO | Chief Tech/Sci/R&D Officer | 59 | 97-12-31 |
Eric Terhaerdt
COO | Chief Operating Officer | - | 18-12-31 |
Diane Weiser
IRC | Investor Relations Contact | - | 15-03-31 |
John Faurescu
LAW | General Counsel | - | - |
Yulymae Dinapoli
HRO | Human Resources Officer | - | 21-10-31 |
Jeff Lotz
SAM | Sales & Marketing | - | 21-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy Wysenski
BRD | Director/Board Member | 66 | 20-11-19 |
Edward Kaye
BRD | Director/Board Member | 75 | 16-05-19 |
Santo Costa
BRD | Director/Board Member | 78 | 10-09-30 |
B. Parshall
BRD | Director/Board Member | 70 | 13-02-06 |
Wendell Wierenga
BRD | Director/Board Member | 76 | 11-02-08 |
John Henderson
CHM | Chairman | 79 | 09-01-31 |
Robert Blum
CEO | Chief Executive Officer | 60 | 98-06-30 |
Director/Board Member | 63 | 22-04-07 | |
Muna Bhanji
BRD | Director/Board Member | 61 | 21-02-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 114,577,882 | 113,953,355 ( 99.45 %) | 0 | 99.45 % |
Company contact information
Cytokinetics, Inc.
350 Oyster Point Boulevard
94080, South San Francisco
+650 624 3000
http://www.cytokinetics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.26% | 5.06B | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.40% | 21.83B | |
-10.63% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- CYTK Stock
- Company Cytokinetics, Incorporated